Table 7.
Prececal digestibility/ disappearance (%) | Efficiency of retention (%) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADG (g/bird) | ADFI (g/bird) | G:F (g/g) | Daily N accretion (g/bird) | ME (MJ/kg DM) | MEn (MJ/kg DM) | P | InsP6 | Ca | P | Ca | |||
Treatments 1 | |||||||||||||
SB1 | Without MCP | NES | 34.8 | 70.5 | 0.51 | 1.81 | 14.4 | 13.7 | 43d | 45c | 66a | 51e | 39e |
SB2 | 1,500Phy | 40.9 | 74.8 | 0.56 | 1.97 | 14.5 | 13.7 | 66b | 75b | 65a | 74b | 52c | |
SB3 | 3,000Phy | 44.9 | 76.8 | 0.60 | 2.05 | 14.5 | 13.8 | 76a | 92a | 64a | 82a | 61a | |
SB1+ | With MCP | NES | 41.6 | 75.3 | 0.57 | 2.03 | 14.4 | 13.6 | 49c | 21d | 57b | 54d | 47d |
SB2+ | 1,500Phy | 43.4 | 75.2 | 0.59 | 2.05 | 14.6 | 13.8 | 61b | 74b | 49c | 69c | 59a | |
SB3+ | 3,000Phy | 48.8 | 79.6 | 0.63 | 2.14 | 14.6 | 13.9 | 64b | 89a | 47c | 68c | 57b | |
Pooled SEM | 1.4 | 1.4 | 0.010 | 0.03 | 0.08 | 0.08 | 2.6 | 2.3 | 2.1 | 0.8 | 0.9 | ||
Main effects | |||||||||||||
Mineral P (M) | Without MCP | 40.2B | 74.0B | 0.55B | 1.94B | 14.5 | 13.7 | –2 | – | – | – | – | |
With MCP | 44.6A | 76.7A | 0.60A | 2.07A | 14.5 | 13.8 | – | – | – | – | – | ||
Pooled SEM | 1.0 | 0.8 | 0.008 | 0.03 | 0.06 | 0.05 | |||||||
Enzyme1 (E) | NES | 38.2C | 72.9B | 0.54C | 1.92B | 14.4 | 13.7B | – | – | – | – | ||
1,500Phy | 42.2B | 75.0B | 0.58B | 2.01AB | 14.5 | 13.8AB | – | – | – | – | – | ||
3,000Phy | 46.8A | 78.2A | 0.61A | 2.10A | 14.6 | 13.9A | – | – | – | – | – | ||
Pooled SEM | 1.1 | 1.0 | 0.009 | 0.03 | 0.06 | 0.06 | |||||||
ANOVA | M | <0.001 | 0.019 | <0.001 | 0.002 | 0.359 | 0.407 | 0.070 | <0.001 | <0.001 | <0.001 | <0.001 | |
(P-values) | E | <0.001 | 0.001 | <0.001 | 0.004 | 0.066 | 0.032 | <0.001 | <0.001 | 0.005 | <0.001 | <0.001 | |
M × E | 0.188 | 0.268 | 0.125 | 0.245 | 0.434 | 0.433 | <0.001 | <0.001 | 0.044 | <0.001 | <0.001 |
1SB = soybean meal; 1–3 indicates enzyme supplementation in the following sequence: NES = no enzyme supplemented; 1,500Phy = 1,500 FTU phytase/kg; 3,000Phy = 3,000 FTU phytase/kg; + indicates monocalcium phosphate supplementation.
2Not presented because of significant interactions (P < 0.050) between main effects.
a-fIn case of significant interactions (P < 0.050) between main effects: different lowercase letters indicate significant differences (P < 0.050) between treatments.
A-CIn case of not significant interactions (P ≥ 0.050) between main effects: different capital letters indicate significant differences (P < 0.050) within the main effects M or E.